Nicole Streiner

2.4k total citations
16 papers, 1.4k citations indexed

About

Nicole Streiner is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Nicole Streiner has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Nicole Streiner's work include PI3K/AKT/mTOR signaling in cancer (3 papers), Synthesis and biological activity (2 papers) and Cancer Mechanisms and Therapy (2 papers). Nicole Streiner is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (3 papers), Synthesis and biological activity (2 papers) and Cancer Mechanisms and Therapy (2 papers). Nicole Streiner collaborates with scholars based in United States and Australia. Nicole Streiner's co-authors include Adam Siddiqui-Jain, Sean O’Brien, David M. Ryckman, Denis Drygin, Kenna Anderes, William G. Rice, Caroline B. Ho, Mayuko Omori, Chris Proffitt and Michael K. Schwaebe and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

Nicole Streiner

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Streiner United States 9 1.1k 312 159 114 105 16 1.4k
Chris Proffitt United States 7 1.4k 1.2× 362 1.2× 116 0.7× 81 0.7× 140 1.3× 12 1.7k
Peter Drueckes Switzerland 15 727 0.6× 290 0.9× 173 1.1× 87 0.8× 96 0.9× 24 1.2k
Caroline B. Ho United States 10 1.6k 1.4× 405 1.3× 167 1.1× 114 1.0× 147 1.4× 15 1.9k
Josh Bliesath United States 6 1.3k 1.1× 284 0.9× 106 0.7× 63 0.6× 109 1.0× 13 1.5k
Michael K. Schwaebe United States 13 1.4k 1.2× 294 0.9× 290 1.8× 63 0.6× 109 1.0× 21 1.7k
Linda Kessler United States 14 746 0.7× 352 1.1× 137 0.9× 62 0.5× 75 0.7× 38 1.1k
Gretchen M. Unger United States 17 1.2k 1.1× 438 1.4× 115 0.7× 115 1.0× 181 1.7× 29 1.6k
Ekaterina Bassett United States 14 801 0.7× 510 1.6× 101 0.6× 86 0.8× 186 1.8× 15 1.2k
Nanni Huser United States 8 737 0.6× 238 0.8× 79 0.5× 73 0.6× 84 0.8× 15 999
Suzanne Leijen Netherlands 13 770 0.7× 728 2.3× 227 1.4× 80 0.7× 98 0.9× 19 1.3k

Countries citing papers authored by Nicole Streiner

Since Specialization
Citations

This map shows the geographic impact of Nicole Streiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Streiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Streiner more than expected).

Fields of papers citing papers by Nicole Streiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Streiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Streiner. The network helps show where Nicole Streiner may publish in the future.

Co-authorship network of co-authors of Nicole Streiner

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Streiner. A scholar is included among the top collaborators of Nicole Streiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Streiner. Nicole Streiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Opsahl, Alan, Dingzhou Li, Nicole Streiner, et al.. (2021). Characterizing Intra-Tumor and Inter-Tumor Variability of Immune Cell Infiltrates in Murine Syngeneic Tumors. American Journal Of Pathology. 191(12). 2133–2146. 2 indexed citations
2.
Siddiqui-Jain, Adam, Joshua Bliesath, Mayuko Omori, et al.. (2012). CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy. Molecular Cancer Therapeutics. 11(4). 994–1005. 86 indexed citations
3.
Pierre, Fabrice, Adam Siddiqui-Jain, Nicole Streiner, et al.. (2012). Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells. Bioorganic & Medicinal Chemistry Letters. 22(9). 3327–3331. 28 indexed citations
4.
Bliesath, Joshua, Nanni Huser, Mayuko Omori, et al.. (2012). Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells. Cancer Letters. 322(1). 113–118. 59 indexed citations
5.
Streiner, Nicole, et al.. (2012). Abstract 5270: Evaluation of Cell-able spheroid culture system for culturing patient derived primary tumor cells. Cancer Research. 72(8_Supplement). 5270–5270. 1 indexed citations
6.
Pierre, Fabrice, Eric Stefan, Adam Siddiqui-Jain, et al.. (2011). 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity. Bioorganic & Medicinal Chemistry Letters. 21(22). 6687–6692. 46 indexed citations
7.
Pierre, Fabrice, Sean O’Brien, Mustapha Haddach, et al.. (2011). Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties. Bioorganic & Medicinal Chemistry Letters. 21(6). 1687–1691. 28 indexed citations
8.
Tseng, Robert, et al.. (2011). PP 64 Predictive assays for targeted therapeutics using image-based high content analysis of patient-derived tumor models. European Journal of Cancer. 47. S28–S28. 1 indexed citations
9.
10.
Drygin, Denis, Amy Lin, Josh Bliesath, et al.. (2010). Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth. Cancer Research. 71(4). 1418–1430. 462 indexed citations
11.
Siddiqui-Jain, Adam, Denis Drygin, Nicole Streiner, et al.. (2010). CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy. Cancer Research. 70(24). 10288–10298. 421 indexed citations
12.
13.
Anderes, Kenna, Nicole Streiner, May Omori, et al.. (2010). Effect of CX-4945, a selective bioavailable small molecule inhibitor of protein kinase CK2, on gemcitabine antitumor activity in A2780 ovarian cancer.. Journal of Clinical Oncology. 28(15_suppl). e13522–e13522. 3 indexed citations
14.
Drygin, Denis, Josh Bliesath, Caroline B. Ho, et al.. (2009). Abstract C198: CX-4945, a novel small molecule inhibitor of CK2 protein kinase, reduces hyperactivated Akt signaling and synergizes with Akt inhibitors in breast cancer cells. Molecular Cancer Therapeutics. 8(12_Supplement). C198–C198. 1 indexed citations
15.
Millar, Lynnae K., Nicole Streiner, Sandra Y. Yamamoto, et al.. (2005). Early Placental Insulin-Like Protein (INSL4 or EPIL) in Placental and Fetal Membrane Growth1. Biology of Reproduction. 73(4). 695–702. 22 indexed citations
16.
Seenisamy, Jeyaprakashnarayanan, Bashyam Sridevi, Vijay Gokhale, et al.. (2005). Design and Synthesis of an Expanded Porphyrin That Has Selectivity for the c-MYC G-Quadruplex Structure. Journal of the American Chemical Society. 127(9). 2944–2959. 271 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Proffitt Breakdown of academic impact, for papers by Peter Drueckes Breakdown of academic impact, for papers by Caroline B. Ho Breakdown of academic impact, for papers by Josh Bliesath Breakdown of academic impact, for papers by Michael K. Schwaebe Breakdown of academic impact, for papers by Linda Kessler Breakdown of academic impact, for papers by Gretchen M. Unger Breakdown of academic impact, for papers by Ekaterina Bassett Breakdown of academic impact, for papers by Nanni Huser Breakdown of academic impact, for papers by Suzanne Leijen
Rankless by CCL
2026